1. Home
  2. VUZI vs OABI Comparison

VUZI vs OABI Comparison

Compare VUZI & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vuzix Corporation

VUZI

Vuzix Corporation

HOLD

Current Price

$2.55

Market Cap

246.0M

Sector

Technology

ML Signal

HOLD

Logo OmniAb Inc.

OABI

OmniAb Inc.

HOLD

Current Price

$1.70

Market Cap

277.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VUZI
OABI
Founded
1997
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
246.0M
277.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VUZI
OABI
Price
$2.55
$1.70
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.67
AVG Volume (30 Days)
1.1M
430.2K
Earning Date
03-12-2026
03-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,310,001.00
$21,094,000.00
Revenue This Year
$5.53
N/A
Revenue Next Year
$110.00
$66.20
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.36
52 Week Low
$1.47
$1.22
52 Week High
$4.82
$4.02

Technical Indicators

Market Signals
Indicator
VUZI
OABI
Relative Strength Index (RSI) 41.80 39.63
Support Level $2.46 $1.64
Resistance Level $2.75 $1.88
Average True Range (ATR) 0.18 0.13
MACD -0.00 -0.01
Stochastic Oscillator 39.26 18.84

Price Performance

Historical Comparison
VUZI
OABI

About VUZI Vuzix Corporation

Vuzix Corp is engaged in the design, manufacture, and marketing of Artificial Intelligence (AI)-powered Smart Glasses, Waveguides, and Augmented Reality (AR) technologies. Its solutions serve the enterprise, medical, defense, security, and select consumer markets, offering cutting-edge wearable computing and display technologies that enhance productivity and operational efficiency. Its products include near-eye displays (NEDs), heads-up displays (HUDs), and wearable computing devices. Geographically, the company generates a majority of its revenue from the United States and also has a presence in Japan, the Netherlands, and other countries.

About OABI OmniAb Inc.

OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.

Share on Social Networks: